Home / Publications / China Encourages Innovative Drug by Modifying Its...

China Encourages Innovative Drug by Modifying Its Drug Classification Rules

China Insight - Lifesciences

05/04/2016

Following the new rules of classification of medical devices effective as of 1st January 2016, the China Food and Drug Administration (“CFDA”) issued a circular regarding the reform of chemical drug registration classification on 4 March 2016 (“Circular”). This new Circular has come into force on the date of publication.

Please click the below Source link to read more details.

Source
China Insight - Lifesciences Update: Following the new rules...
Read more

Authors

Portrait ofNicolas Zhu
Nicolas Zhu
Partner
Shanghai
Lingyun Rao, LL.M.